Home›Search›Journal of the Egyptian National Cancer Institute

Journal of the Egyptian National Cancer Institute

Springer Science and Business Media Deutschland GmbH · Germany · Est. 1982

ISSN1110-0362eISSN2589-0409
SJR Q3✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access
78
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
◆ WoS ESCI56
✓ Corroboration (4 more)+22
Total78
Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
11
weeks to publish · journal-reported
Average · vs ~15 wk median
Q3
SJR Rank
Top 75% in field
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.551
H-Indexi
35
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIPi
0.683
Total Worksi
651
Total Citationsi
6,604
2yr Mean Citednessi
2.01
Open Impact Factor alternative
Retractions
2
Source: Retraction Watch

Aims & Scope

As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.

General Information

Country / RegionGermany
Primary LanguageEnglish
1st Year Published1982
FrequencyQuarterly
StatusActive (last: 2026)
Total Publications651
Publisher OrgSpringer Nature
OA Since2010
Visit Journal Website

Submission Info

APC Cost💎 Diamond OA — Free
Peer ReviewDouble-blind
Review Time~11 weeks
Acceptance Rate—
OA LicenseCC BY, CC BY-NC-ND
OA Rate—

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes
📦 Long-term Preservation
CLOCKSSPortico

Think.Check.Submit Compliance

11/12 · 92%
✅
Do you know the journal / publisher?
Springer Science and Business Media Deutschland GmbH
✅
Does the journal have a website?
✓ Linked
✅
Is the ISSN verified?
1110-0362 / 2589-0409
✅
Indexed in a trusted database?
WoS, Scopus, DOAJ
✅
Peer review process documented?
Double-blind
❌
Follows ethical publishing standards (COPE)?
N/A
✅
APC fees clearly disclosed?
No APC (Free)
✅
Not on predatory/blacklists?
✓ Clean
✅
Long-term digital preservation?
CLOCKSS, Portico
✅
Plagiarism detection in place?
Yes
✅
Listed in DOAJ (verified OA)?
DOAJ verified
✅
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
12
160
2019
44
817
2020
40
525
2021
57
529
2022
44
271
2023
44
179
2024
83
177
2025
39
4
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ3
Cancer ResearchQ4

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Cancer ResearchOncology

Research Topics (OpenAlex)

Breast Cancer Treatment StudiesLymphoma Diagnosis and TreatmentSarcoma Diagnosis and TreatmentHead and Neck Cancer StudiesAdvanced Radiotherapy TechniquesEndometrial and Cervical Cancer TreatmentsCancer Immunotherapy and BiomarkersGlioma Diagnosis and TreatmentBladder and Urothelial Cancer TreatmentsAcute Lymphoblastic Leukemia research

Frequently asked questions about Journal of the Egyptian National Cancer Institute

Is Journal of the Egyptian National Cancer Institute a predatory journal?

PubScope has no integrity flags on record for Journal of the Egyptian National Cancer Institute: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 78/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Journal of the Egyptian National Cancer Institute?

Journal of the Egyptian National Cancer Institute is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.01.

Is Journal of the Egyptian National Cancer Institute indexed in Scopus and Web of Science?

Journal of the Egyptian National Cancer Institute is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Journal of the Egyptian National Cancer Institute?

As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer de

How much does it cost to publish in Journal of the Egyptian National Cancer Institute?

Journal of the Egyptian National Cancer Institute is a Diamond open-access journal — there is no article processing charge (APC) to publish.

You May Also Like

See all →
Frontiers in Oncology
Frontiers Media S.A.
SJR Q2SCIEOA
Oncology and Translational Medicine
Lippincott Williams and Wilkins
SJR Q4💎 Free APC
Oncologie
Walter de Gruyter GmbH
SJR Q3SCIEOA
Visualized Cancer Medicine
EDP Sciences
OA
Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref